Purolite, an Ecolab company and manufacturer of synthetic and agarose-based resins used in the bioprocessing industry, has been awarded the prestigious Queen’s Award for Enterprise in the International Trade category.
Now in its 56th year, The Queen’s Award for Enterprise acknowledges firms that have excelled in exporting, social or environmental good work or innovation.
Purolite is one of 232 organisations to be recognised with the award. The company was chosen for demonstrating ‘outstanding success in innovation and international trade’, as well as the resilience the business has shown in unprecedented times.
Leighton Davies, Finance Director at Purolite, has received an invitation to the Buckingham Palace awards reception hosted by Prince Charles.
Hayley Crowe, SVP and General Manager of Purolite, said: “It’s a tremendous honour to have won the Queen’s Award for Enterprise. I’m immensely proud of this achievement and would like to thank the fantastic teams we have in place all over the world, as well as the continued support of our valued customers.”
Chris Major, UK General Manager at Purolite’s Healthcare & Life Sciences division in Llantrisant, north of Cardiff, said: “We’ve worked hard to deliver quality, reliable and industry-leading resins to our customers, and the continued growth of our customer base is testament to this.
“The Agarose Life Science business is the growth engine of the Purolite group and positions the company well for the next decade and beyond. Exports of agarose resins account for the majority of our turnover, and this trend is expected to continue.”
Agarose resins are used in a variety of biopharmaceuticals approved by US Food and Drug Administration (FDA) in the manufacture of modern medicines targeting the treatment of cancer, rheumatoid arthritis, age-related diseases and in developing treatments and vaccines that combat the COVID-19 pandemic.
